Cresset Asset Management »

Urogen Pharma shares owned by Cresset Asset Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Cresset Asset Management from 13F filings

Historical chart of Cresset Asset Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Cresset Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Cresset Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $234k 17k 14.01
2023-06-30 $178k 17k 10.35

More positions owned by Cresset Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation Put Option (MSFT)
Arista Networks Put Option (ANET)
Ishares Tr Core S&p500 Etf (IVV)
Meta Platforms Cl A Call Option (META)
Ishares Tr Msci Eafe Etf Put Option (EFA)
Caterpillar Put Option (CAT)
Philip Morris International Put Option (PM)
Apple Put Option (AAPL)
Eli Lilly & Co. (LLY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Scp Etf (IJR)
Tesla Motors Call Option (TSLA)
Mondelez Intl Cl A (MDLZ)

View all positions for Cresset Asset Management

Top funds holding Urogen Pharma

RA Capital Management
Dr. Jeffrey R. Jay, M.D.
Credit Suisse
Harel Insurance Investments & Financial Services
Migdal Insurance & Financial Holdings
Millennium Management
Opaleye Management
Superstring Capital Management
Laurion Capital Management
Wells Fargo & Company
Citadel Advisors
Vanguard Group
ARK Investment Management
AlphaCentric Advisors
Schonfeld Strategic Advisors

View all funds holding Urogen Pharma